BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• 

  Job Trends

  Massachusetts’ Agenus to Phase Out 20% of Jobs, Shutter Switzerland Facility in Restructuring

  March 30, 2017

   · 

  3 min read
• 

  Policy

  Novartis AG Jumps Into the Front of the CAR-T Line With Speedy Review of New Leukemia Drug

  March 30, 2017

   · 

  3 min read
• 

  Genetown

  Cambridge Biotech Solid Biosciences Rakes in $50 Million Series C to Move DMD Program Forward

  March 30, 2017

   · 

  2 min read
• Policy

  The Senator From Ground Zero Of The Opioid Crisis Has No Idea What He’s Talking About

  March 30, 2017

   · 

  1 min read
• BioForest

  Top Biotech Stocks For Growth Investors

  March 30, 2017

   · 

  1 min read
• Bio NC

  Researchers Control Soft Robots Using Magnetic Fields, North Carolina State University Study Reveals

  March 30, 2017

   · 

  1 min read
• BioMidwest

  Toward Glow-In-The-Dark Tumors: New Fluorescent Probe Could Light Up Cancer, Michigan Tech Study Reveals

  March 30, 2017

   · 

  1 min read
• Policy

  How Much Pain Will Congress Inflict On These Opioid Drugmakers’ Stocks?

  March 30, 2017

   · 

  1 min read
• 

  Drug Development

  Tiny Massachusetts Phenom Corbus Plunges Despite Reporting Positive Phase II CF Data

  March 30, 2017

   · 

  2 min read
• Pharm Country

  Is Vertex’s New CF Drug Unprecedented? Incremental? Expensive? Maybe All Three

  March 30, 2017

   · 

  1 min read